Trial intelligence / Profile preview

Clarithromycin for Generalized Aggressive Periodontitis

NCT02829983Completed

Sponsor
Universidade Estadual Paulista
Start
Mar 2014
Primary completion
Aug 2015
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in Generalized Aggressive Periodontitis (GAP) comparing Clarithromycin Group with Placebo Group (2 arms). Primary endpoint: Clinical Attachment Level at 6 months. Started Mar 2014; status: completed.

02

Drugs

clarithromycin
03

Conditions

Generalized Aggressive Periodontitis (GAP)

Beyond the preview

Go deeper on NCT02829983.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02829983.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call